je.st
news
Tag: demonstrates
Nordson ASYMTEK Introduces Fluid Dispensing Systems and Demonstrates...
2014-04-15 07:35:22| Industrial Machines - Topix.net
Nordson ASYMTEK, a Nordson company , a leader in dispensing, jetting, and conformal coating equipment and technologies, will be exhibiting new jetting, dispensing, and conformal coating systems at NEPCON China in booth #C-1G10, April 23-25, 2014 at the Shanghai World Expo Exhibition & Convention Center, Shanghai, China.
Tags: systems
fluid
demonstrates
introduces
Nordson ASYMTEK Introduces Fluid Dispensing Systems and Demonstrates New Dispensing ...
2014-04-14 06:00:00| Industrial Newsroom - All News for Today
~ The new Quantum and Spectrum II platforms deliver fast & accurate dispensing<br /> <br /> NEPCON China Booth #C-1G10<br /> <br /> Carlsbad, CA, USA - Nordson ASYMTEK, a Nordson company (NASDAQ: NDSN), a leader in dispensing, jetting, and conformal coating equipment and technologies, will be exhibiting new jetting, dispensing, and conformal coating systems at NEPCON China in booth #C-1G10, April 23-25, 2014 at the Shanghai World Expo Exhibition & Convention Center, Shanghai, China.<br /> <br ...This story is related to the following:Paints and CoatingsSolder Paste Dispensers | Adhesive Dots |
Tags: systems
fluid
demonstrates
introduces
Sikorsky demonstrates CH-53K structural strength
2014-04-14 01:00:00| Naval Technology
The US Naval Air Systems Commands Sikorsky CH-53K Super Stallion heavy-lift helicopter has successfully completed an initial series of tests required to verify its structural strength.
Tags: strength
structural
demonstrates
sikorsky
Mercks Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity in Hard-to-Cure Patients with HCV Genotype 1 Infection
2014-04-11 07:00:00| Merck.com - Corporate News
Dateline City: WHITEHOUSE STATION, N.J. Clinical Findings Support Initiation of C-EDGE Phase 3 Program WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced interim results from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of an all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor, among patients with chronic HCV Genotype 1 infection (GT1). Language: English Contact: MerckMedia Contacts:Caroline Lappetito, 267-305-7639Sarra Herzog, 201-669-6570orInvestor Contacts:Carol Ferguson, 908-500-1101Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: activity
combination
patients
therapy
Thinklogical Demonstrates Modular and Flexible Secure Visual Computing Solutions for C4ISR at ...
2014-04-10 06:00:00| Industrial Newsroom - All News for Today
Rapid Reconfiguration Capability Supports Advanced Collaboration, Nimble Response to Changing Mission Requirements and Improved Facility Efficiency<br /> <br /> MILFORD, Conn. - Thinklogical®, a worldwide leading provider of secure, high-performance KVM signal extension and switching systems for video-rich, big data computing environments, announced today it will be demonstrating its modular and flexible visual computing solutions for C4ISR at its booth #1051 at GEOINT Symposium (<a ...This story is related to the following:Computer Hardware and PeripheralsSearch for suppliers of: Computer Systems |
Tags: at
solutions
secure
visual
Sites : [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] next »